Phase 3 Trial – Benlysta

Phase 3 Trial Finds Benlysta Significantly Improves Kidney Response in People with Lupus Nephritis UPDATE 16/09/2020 In new results on the international phase 3 clinical trial (BLISS-LN) of the drug Benlysta (belimumab), researchers found that Benlysta reduced the risk of worsening kidney function during the study by almost 50%, compared with standard therapy alone. The…

RUNWEST 2020

Hi there! I’m making a difference and running 12km in October for a cause that’s close to my heart. My girlfriend has recently started treatment for Lupus and has battled with several of its symptoms for the past 7 years. With this, we no longer need to keep searching for answers and can start treating…